NDA and supplemental NDA submitted for low dose aspirin/esomeprazole (Nexium) combinations - MPR
Links shared publicly online about this topic.
- 2,068total visits
NDA and supplemental NDA submitted for low dose aspirin/esomeprazole (Nexium) combinations - MPR
empr.com —
AstraZeneca announced the submission of a new drug application (NDA) to the FDA for the use of low dose aspirin with Nexium (esomeprazole magnesium) to reduce the risk of low dose aspirin-associated gastric and/or duodenal ulcers in patients at risk of cardio- and cerebrovascular events.
View full resource at empr.com
Tags: Duodenal Ulcer Medication, Mineral, Magnesium, Drug, FDA, Nexium, Aspirin, AstraZeneca
Most Recently Shared on May 4, 2009 at 5:28 pm By:
MPR News: NDA and supplemental NDA submitted for low dose aspirin/esomeprazole (Nexium) combinations: A.. http://tinyurl.com/d7u4qv
AstraZeneca submits NDA for low dose aspirin/esomeprazole combination product
astrazeneca-us.com — “Read how AstraZeneca also submits sNDA for NEXIUM Capsules for risk reduction of low-dose aspirin-associated peptic ulcer.” View full resource at astrazeneca-us.com
Most Recently Shared on May 4, 2009 at 1:52 pm By:
eyeonfda Pharma and Health Lawyer
AstraZeneca submits NDA for low dose aspirin/esomeprazole combination product - http://twurl.nl/o8w2ad
Advertisement
